UBS S&P 500 ESG UCITS ETF USD A Acc is a equity ETF from UBS tracking the S&P 500 ESG index through physical replication. Domiciled in Ireland and launched in 2019, the fund manages about 2 bn € and charges a TER of 0.10% — 10 € per year on a €10,000 investment. Income is automatically reinvested in the fund (accumulating).
UBS S&P 500 ESG UCITS ETF USD A Acc competes with 11 other products on the same index (S&P 500 ESG): it ranks 3rd by fund size and 5th by ongoing cost, with a TER of 0.10% against a group median of 0.10%. It has been listed since 2019, 7 years of track record — the oldest in its comparison group.
On a €10,000 investment the TER costs 10 € a year. The cheapest of the group is iShares S&P 500 ESG UCITS ETF USD (Acc) EUR at 0.07%, or 7 € on the same amount: a difference of 3 € every year, roughly 30 € over ten years before compounding.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 40.0% of the portfolio.
Income is accumulated: no distribution is paid out, the share price absorbs it. In a savings plan this removes the need to reinvest dividends by hand. The fund is denominated in USD. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
Irish domicile lets the fund apply the Ireland–US tax treaty, with 15% withholding instead of 30% on US dividends received by the fund.
| NVIDIA Corporation | 12.1% |
| Microsoft Corporation | 6.9% |
| Alphabet Inc Class A | 5.2% |
| Alphabet Inc Class C | 4.2% |
| Micron Technology Inc | 3.3% |
| Eli Lilly and Company | 2.4% |
| Intel Corporation | 1.7% |
| Applied Materials Inc | 1.4% |
| Visa Inc. Class A | 1.4% |
| Lam Research Corp | 1.4% |
| Borsa Italiana | SPESG | EUR |
| XETRA | 4UBQ | EUR |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.